Ruggiero Fumarulo

Bari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Increased concentration of soluble leukocyte-associated immunoglobulin-like receptor in sera from patients with blistering diseases: possible pathophysiological implications?

Increased concentration of soluble leukocyte-associated immunoglobulin-like receptor in sera from patients with blistering diseases: possible pathophysiological implications?

Journal: Minerva medica

Published: February 14, 2022

Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review).

Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review).

Journal: Oncology reports

Published: October 30, 2018

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?

Journal: Neoplasia (New York, N.Y.)

Published: September 10, 2018

Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.

Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.

Journal: The Journal of pathology

Published: June 19, 2018

Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.

Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.

Journal: Journal of nephrology

Published: April 17, 2018

Bullous Pemphigoid and Neurologic Diseases: Toward a Specific Serologic Profile?

Bullous Pemphigoid and Neurologic Diseases: Toward a Specific Serologic Profile?

Journal: Endocrine, metabolic & immune disorders drug targets

Published: February 16, 2018

IL-6/IL-10 Ratio as A Prognostic and Predictive Marker of the Severity of Inherited Epidermolysis Bullosa.

IL-6/IL-10 Ratio as A Prognostic and Predictive Marker of the Severity of Inherited Epidermolysis Bullosa.

Journal: Iranian journal of immunology : IJI

Published: December 26, 2017

Microenvironment drug resistance in multiple myeloma: emerging new players.

Microenvironment drug resistance in multiple myeloma: emerging new players.

Journal: Oncotarget

Published: May 05, 2016

Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients.

Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients.

Journal: Leukemia

Published: July 07, 2015

Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro.

Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro.

Journal: European journal of haematology

Published: November 07, 2014

Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies.

Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies.

Journal: Leukemia

Published: July 10, 2013

Increase in interleukin-8 production from circulating neutrophils upon antibiotic therapy in cystic fibrosis patients.

Increase in interleukin-8 production from circulating neutrophils upon antibiotic therapy in cystic fibrosis patients.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: November 04, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026